×
About 847 results

ALLMedicine™ Bacterial Conjunctivitis Center

Research & Reviews  261 results

Using Historical Data to Support Approval of Drug Products for Ophthalmia Neonatorum: I...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7747033
JAMA Ophthalmology; Sun H, Temeck JW et. al.

Dec 17th, 2020 - Off-label treatment was common for ophthalmia neonatorum because only erythromycin ointment had been approved by the US Food and Drug Administration (FDA) for this indication. Ophthalmia neonatorum was previously considered a different indication ...

Quinolone immediate hypersensitivity due to topical ophthalmic preparations: a case rep...
https://doi.org/10.1111/1346-8138.15669
The Journal of Dermatology; Ajima S, Sano Y et. al.

Oct 28th, 2020 - Ophthalmic quinolone preparations are widely used for the treatment of eye diseases; however, there are only a few reported cases of immediate hypersensitivity due to such medications. Here, we present a case of immediate hypersensitivity induced ...

Characterization of baseline polybacterial versus monobacterial infections in three ran...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7447040
PloS One; DeCory HH, Sanfilippo CM et. al.

Aug 25th, 2020 - To date, studies examining polymicrobial infections in ocular disease have mostly been limited to keratitis or endophthalmitis. We characterized polybacterial infections compared to monobacterial infections in prior clinical studies evaluating bes...

Stimulus Responsive Ocular Gentamycin-Ferrying Chitosan Nanoparticles Hydrogel: Formula...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335305
International Journal of Nanomedicine; Alruwaili NK, Zafar A et. al.

Jul 8th, 2020 - The present study was designed to study the gentamycin (GTM)-loaded stimulus-responsive chitosan nanoparticles to treat bacterial conjunctivitis. GTM-loaded chitosan nanoparticles (GTM-CHNPs) were prepared by ionotropic gelation method and further...

COVID-19 and Telehealth: Prevention of Exposure in a Medically Complex Patient With a M...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7313502
The Journal of Adolescent Health : Official Publication O... Chavis A, Bakken H et. al.

Jun 30th, 2020 - The novel coronavirus disease-2019 (COVID-19) was declared a pandemic by the World Health Organization on March 11, 2020. We discuss a less common presentation of COVID-19 in a patient where the use of telemedicine technology prevented the exposur...

see more →

Guidelines  1 results

Conjunctivitis
https://www.aao.org/preferred-practice-pattern/conjunctivitis-ppp-2018

Nov 12th, 2018 - Evidence-based update using Cochrane Eyes and Vision Group-identified systematic reviews for the initial evaluation of conjunctivitis patients and discussion of associated or predisposing factors.

see more →

Drugs  147 results see all →

Clinicaltrials.gov  425 results

Besivance - besifloxacin suspension-A-S Medication Solutions
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b111b1ab-10b0-4378-8aef-e51d5274306c

Feb 21st, 2021 - BESIVANCE ® (besifloxacin ophthalmic suspension) 0.6%, is indicated for the treatment of bacterial conjunctivitis caused by susceptible isolates of the following bacteria: Aerococcus viridans* CDC coryneform group G Corynebacterium pseudodiphtheri...

Polymyxin b sulfate and trimethoprim - polymyxin b sulfate and trimethoprim solution-NuCare Pharmaceuticals,Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=60f5cfcf-cdb2-0e45-e053-2991aa0ae85a

Feb 11th, 2021 - Polymyxin B Sulfate and Trimethoprim Ophthalmic Solution is indicated in the treatment of surface ocular bacterial infections, including acute bacterial conjunctivitis, and blepharoconjunctivitis, caused by susceptible strains of the following mic...

Moxifloxacin hydrochloride - moxifloxacin hydrochloride solution-Upsher-Smith Laboratories, LLC
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5a5d72e2-aa39-4ead-af72-d3cabe72a5b7

Feb 7th, 2021 - Moxifloxacin ophthalmic solution is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms: Corynebacterium speciesEfficacy for this organism was studied in fewer than 10 infections. Microc...

Gatifloxacin - gatifloxacin solution/ drops-Lupin Pharmaceuticals, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3deb52f2-0580-45ac-9bbd-c0c9e3f13a37

Feb 2nd, 2021 - Gatifloxacin ophthalmic solution, 0.5% is a quinolone antimicrobial indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms: Haemophilus influenzae, Staphylococcus aureus, Staphylococcus epi...

Polymyxin b sulfate and trimethoprim - polymyxin b sulfate and trimethoprim solution-REMEDYREPACK INC.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2a040ba4-54bd-41e4-b519-01ca6a59658f

Jan 17th, 2021 - Polymyxin B Sulfate and Trimethoprim Ophthalmic Solution is indicated in the treatment of surface ocular bacterial infections, including acute bacterial conjunctivitis, and blepharoconjunctivitis, caused by susceptible strains of the following mic...

see more →

News  13 results

Desquamating pustular rash
https://www.mdedge.com/ccjm/article/213108/dermatology/desquamating-pustular-rash?channel=325
Kevin Bryan Uy Lo, MD, Zurab Azmaiparashvili, MD

Dec 2nd, 2019 - A 66-year-old man presented with burning pain and erythema over the left axilla, and pustules that had ruptured and crusted over. The rash also involved the right axilla, trunk, abdomen, and face.

Does this patient have bacterial conjunctivitis?
https://www.mdedge.com/pediatrics/article/208473/infectious-diseases/does-patient-have-bacterial-conjunctivitis?channel=41022
McKenzie Momany, Douglas Paauw, MD, MACP

Sep 20th, 2019 - A 54-year-old pharmacist with a history of gout, hypertension, and conjunctivitis presents for evaluation of pink eye in the summer. The morning before coming into the office, he noticed that his right eye was red and inflamed.

How NOT to Cure Pinkeye (The New York Times)
https://www.medpagetoday.com/primarycare/generalprimarycare/66201

Jun 22nd, 2017 - Antibiotic eye drops cannot treat most pinkeye cases, reported The New York Times. A recent study looked at over 300,000 people diagnosed with pinkeye and found that over 58% were prescribed antibiotics, even though they only work 20% of the time,...

FDA Approves 0.5% Gatifloxacin Eye Drops for Pinkeye
https://www.medscape.com/viewarticle/722280

May 23rd, 2010 - May 24, 2010 — The US Food and Drug Administration (FDA) has approved gatifloxacin 0.5% ophthalmic solution (Zymaxid; Allergan, Inc) for the treatment of bacterial conjunctivitis caused by susceptible strains of Haemophilus influenzae, Staphylococ...

FDA Okays Besifloxacin Drops for Conjunctivitis
https://www.medpagetoday.com/ophthalmology/generalophthalmology/14418

May 28th, 2009 - WASHINGTON, May 28 -- The FDA has approved besifloxacin ophthalmic suspension 0.6% (Besivance) for the treatment of bacterial conjunctivitis. The drug is a novel fluoroquinolone antibiotic found to inhibit production of proinflammatory cytokines i...

see more →